GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,844.50p
   
  • Change Today:
      1.50p
  • 52 Week High: 2,208.00p
  • 52 Week Low: 1,344.00p
  • Currency: UK Pounds
  • Shares Issued: 4,054.82m
  • Volume: 9,313,708
  • Market Cap: £74,791m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

GSK strikes agreement with China's SBP Group, launches final tranche of buyback programme

By Iain Gilbert

Date: Monday 11 May 2026

(Sharecast News) - Drugmaker GSK said on Monday that it has struck an exclusive agreement with Sino Biopharmaceutical subsidiary Chia Tai Tianqing Pharmaceutical to accelerate its chronic hepatitis B treatment, bepirovirsen, in mainland China.

Sales jump at GSK on strong demand for specialty drugs

By Abigail Townsend

Date: Wednesday 29 Apr 2026

(Sharecast News) - GSK posted above-forecast first-quarter profits on Wednesday, boosted by robust demand for its specialist HIV and oncology drugs.

GSK hepatitis B drug secures FDA priority review

By Iain Gilbert

Date: Tuesday 28 Apr 2026

(Sharecast News) - Pharmaceutical giant GSK said on Tuesday that the US Food and Drug Administration had accepted its new drug application for bepirovirsen for priority review, with the drug being assessed as a potential treatment for adults with chronic hepatitis B.

US court rules against GSK in dispute with Anapt... 27-Apr-2026 ShareCast
GSK's Blenrep gets green light from China's NMPA 20-Apr-2026 ShareCast
GSK ovarian, womb cancer drug posts positive res... 13-Apr-2026 ShareCast
GSK's Exdensur gets green light from Chinese reg... 08-Apr-2026 ShareCast
GSK's cholestatic pruritus treatment Lynavoy get... 19-Mar-2026 ShareCast
FDA expands approved age indication for GSK RSV ... 13-Mar-2026 ShareCast
Transaction in Own Shares 10-Mar-2026 ShareCast
Board Committee Change 09-Mar-2026 ShareCast
GSK secures Japan and China reviews for two late... 26-Feb-2026 ShareCast
Director/PDMR Shareholding 25-Feb-2026 ShareCast
GSK to acquire Canada's 35Pharma for $950m 25-Feb-2026 ShareCast
GSK's Exdensur gets green light from European Co... 17-Feb-2026 ShareCast
China's CDE accepts GSK's regulatory filing for ... 10-Feb-2026 ShareCast
JP Morgan raises target price on GSK 09-Feb-2026 ShareCast
Director dealings: GSK chairman raises stake 06-Feb-2026 ShareCast
EU gives GSK's Nucala green light for use in unc... 06-Feb-2026 ShareCast
GSK sees slower sales growth in 2026 as patent l... 04-Feb-2026 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,844.50p
Change Today 1.50p
% Change 0.08 %
52 Week High 2,208.00p
52 Week Low 1,344.00p
Volume 9,313,708
Shares Issued 4,054.82m
Market Cap £74,791m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 14-May-26 19-Feb-26
Paid 09-Jul-26 09-Apr-26
Amount 17.00p 18.00p

Trades for 11-May-2026

Time Volume / Share Price
14:32 0 @ 1,864.50p
14:31 0 @ 1,861.00p
12:15 1,940,384 @ 1,858.00p
12:15 1,940,384 @ 1,858.00p
14:32 0 @ 1,865.00p

GSK Key Personnel

CEO Luke Miels

Top of Page